limula.swiss

Evaluation du site limula.swiss

 Généré le 08 Décembre 2025 02:50

Vieilles statistiques? UPDATE !

Le score est de 48/100

Optimisation du contenu

Titre

Limula – Cell and Gene Therapy Made Easy

Longueur : 40

Parfait, votre titre contient entre 10 et 70 caractères.

Description

Longueur : 0

Très mauvais. Nous n'avons pas trouvé de balise META description sur votre page. Utilisez ce générateur gratuit de balises META en ligne pour créer une description.

Mots-clefs

Très mauvais. Nous n'avons pas trouvé de balise META keywords sur votre page. Utilisez ce générateur gratuit de balises META en ligne pour créer des mots-clés.

Propriétés Open Graph

Cette page ne profite pas des balises META Open Graph. Cette balise permet de représenter de manière riche n'importe quelle page dans le graph social (environnement social). Utilisez ce générateur gratuit de balises META Open Graph pour les créer.

Niveaux de titre

H1 H2 H3 H4 H5 H6
2 7 10 13 12 26
  • [H1] The Future of Cell and Gene Therapy is Automated
  • [H1] The Future of Cell and Gene Therapy is Automated
  • [H2] Life-saving therapies, for everyone.
  • [H2] Combining a bioreactor and a centrifuge into one device, for the first time.
  • [H2] Swiss Made engineering meets cell therapy
  • [H2] We think out of the box.
  • [H2] Be part of our journey!
  • [H2] They believe in what we do, since 2020
  • [H2] Stay up to date!
  • [H3]
  • [H3] The technology developed by Limula has several strong differentiation factors compared to existing solutions, and in particular: ease of use and low hands-on time, no limitations on input cell volume and number, possibility to incubate cells in the device.
  • [H3] Our company wishes to partner with Limula as we see great potential for their solution to support our vision for a decentralised approach to cell therapy manufacturing.
  • [H3] With its innovative technology, Limula is ideally positioned for the future of Cell & Gene Therapy combining lower doses and next-generation ultra-short processes.
  • [H3] The bioreactor developed by Limula is unique and represents an offering complementary to the solutions currently available with a strong differentiation.
  • [H3] We see great potential for Limula to support our vision for a closed and automated approach to CGT manufacturing.
  • [H3] Leadership
  • [H3] Let's talk!
  • [H3] Join us!
  • [H3] Support us!
  • [H4] Our Vision
  • [H4] Our Solution
  • [H4]
  • [H4]
  • [H4]
  • [H4]
  • [H4]
  • [H4]
  • [H4] About Limula
  • [H4] Our team
  • [H4] Contact us
  • [H4] Our Partners
  • [H4] Newsletter
  • [H5] Novel
  • [H5] Automated
  • [H5] Closed
  • [H5] Scalable
  • [H5] Versatile
  • [H5] Intuitive
  • [H5] LUC HENRY
  • [H5] Yann Pierson
  • [H5] Thomas Eaton
  • [H5] Partnering
  • [H5] CAREERS
  • [H5] investment
  • [H6] We reimagined the concept of a bioreactor from the ground up. Our proprietary solution is fit-for-purpose and radically different from existing technologies.
  • [H6] In-situ centrifugation is our unique selling proposition. We can sequence highly complex cell processing steps in a single container without any human intervention.
  • [H6] We reduce contamination risk, limiting open human interventions and ensuring a controlled environment by sequencing all steps in a single closed device.
  • [H6] The unique shape of our bioreactor enables scale-down for process development before scale-up and scale-out for commercial-stage manufacturing.
  • [H6] Our technology has the potential to support a variety of use cases in autologous and allogenic cell therapy, including T cells, hematopoietic stem cells, and more.
  • [H6] Our solution combines an operating unit, consumables and software, into a user-friendly automated platform with intuitive user experience and low hands-on time.
  • [H6] Dr. Boris Calmel Head of Manufacturing, Cell Therapy Center, Paoli-Calmettes Institute
  • [H6] CEO, Cell & Gene Therapy CDMO
  • [H6] Co-Founder and CSO, Cell & Gene Therapy manufacturing automation company
  • [H6] Director Cell & Gene Therapy, large pharmaceutical company
  • [H6] Executive Vice President, Technical Operations, mid-sized biotech company
  • [H6] Luc graduated from the University of Oxford with a DPhil in Chemical Biology and has 10 years of research experience in chemistry, biotechnology and immunology. Before founding Limula, he was a personal advisor to the President of EPFL, Prof. Martin Vetterli. At Limula, his role is to build meaningful partnerships to maximise the impact of our technology.
  • [H6] Yann graduated from EPFL with a PhD in Chemical Biology. He invented, patented and built the first prototype of the technology behind our revolutionary CGT manufacturing platform in his garage during the COVID pandemic lock-down. At Limula, his role is to develop a product that meets the technical and regulatory needs of our customers.
  • [H6] Tom graduated from the University of Basel with a PhD in Material Sciences. Tom has extensive experience in project management, budget tracking, outsourcing and supplier oversight. He has worked for, and consulted to, multinationals, including Deloitte, UBS and SwissRe. At Limula, his role is to establish company processes to support our objectives and reach our potential.
  • [H6] You want to streamline your manufacturing process? We offer early access to our technology to selected partners with an exciting use case.
  • [H6] You have an offering complementary to our solution? We are open to partnerships with all stakeholders in the Cell & Gene Therapy value chain.
  • [H6] Our ambition is to grow our multidisciplinary team of engineers and biologists with a proactive approach to excellence and diversity.
  • [H6] We add more passion and expertise each time we bring someone on board. Explore current opportunities to see if there is something for you.
  • [H6] You are looking for a unique opportunity to engage with one of the most innovative European company active in field of the Cell and Gene Therapy?
  • [H6] We are looking for investors who want to help us deliver on our vision and who are keen make a significant contribution to our success.
  • [H6] Limula SA Biopôle StartLab CH–Lausanne
  • [H6] Privacy Policy Imprint
  • [H6] © 2025 Limula SA
  • [H6] Limula SA Biopôle StartLab CH–Lausanne
  • [H6] Privacy Policy Imprint
  • [H6] © 2023 Limula SA

Images

Nous avons trouvé 41 image(s) sur cette page Web.

11 attribut(s) alt sont vides ou manquants. Ajouter un texte alternatif permet aux moteurs de recherche de mieux comprendre le contenu de vos images.

Ratio texte/HTML

Ratio : 5%

le ratio de cette page texte/HTML est au-dessous de 15 pour cent, ce qui signifie que votre site manque de contenu textuel.

Flash

Parfait, aucun contenu FLASH n'a été détecté sur cette page.

Iframe

Génial, il n'y a pas d'Iframes détectés sur cette page.

Réécriture d'URLs

Bien. Vos liens sont optimisés!

Tiret bas dans les URLs

Parfait! Aucuns soulignements détectés dans vos URLs.

Liens dans la page

Nous avons trouvé un total de 10 lien(s) dont 1 lien(s) vers des fichiers

Texte d'ancre Type Juice
Skip to content Interne Passing Juice
Technology Externe Passing Juice
Products Externe Passing Juice
Data Externe Passing Juice
About Externe Passing Juice
News Externe Passing Juice
Contact Externe Passing Juice
https://limula.ch/wp-content/uploads/2025/06/LIM05-LimOne-DL02-LimeOne.Pres-V9-Fina-EN.STl_V2.mp4 Externe Passing Juice
Privacy Policy Externe Passing Juice
Imprint Externe Passing Juice

Mots-clefs

Nuage de mots-clefs

email company name download cell limula gene first poster therapy

Cohérence des mots-clefs

Mot-clef Contenu Titre Mots-clefs Description Niveaux de titre
limula 15
name 12
cell 12
therapy 11
poster 10

Ergonomie

Url

Domaine : limula.swiss

Longueur : 12

Favicon

Génial, votre site web dispose d'un favicon.

Imprimabilité

Aucun style CSS pour optimiser l'impression n'a pu être trouvé.

Langue

Bien. Votre langue est : en.

Dublin Core

Cette page ne profite pas des métadonnées Dublin Core.

Document

Doctype

HTML 5

Encodage

Parfait. Votre charset est UTF-8.

Validité W3C

Erreurs : 0

Avertissements : 0

E-mail confidentialité

Attention! Au moins une adresse e-mail a été trouvée en texte clair. Utilisez une protection anti-spam gratuite pour cacher vos e-mails aux spammeurs.

HTML obsolètes

Génial! Nous n'avons pas trouvé de balises HTML obsolètes dans votre code.

Astuces vitesse

Excellent, votre site n'utilise pas de tableaux imbriqués.
Mauvais, votre site web utilise des styles css inline.
Mauvais, votre site web contient trop de fichiers CSS (plus de 4).
Mauvais, votre site web contient trop de fichiers javascript (plus de 6).
Parfait : votre site tire parti de gzip.

Mobile

Optimisation mobile

Icône Apple
Méta tags viewport
Contenu FLASH

Optimisation

Sitemap XML

Votre site web dispose d’une sitemap XML, ce qui est optimal.

https://limula.ch/

Robots.txt

http://limula.swiss/robots.txt

Votre site dispose d’un fichier robots.txt, ce qui est optimal.

Mesures d'audience

Manquant

Nous n'avons trouvé aucun outil d'analytics sur ce site.

Un outil de mesure d'audience vous permet d'analyser l’activité des visiteurs sur votre site. Vous devriez installer au moins un outil Analytics. Il est souvent utile d’en rajouter un second, afin de confirmer les résultats du premier.

PageSpeed Insights

Dispositif
Les catégories

Website-SEO-Überprüfung

Website-SEO-Überprüfung est un outil gratuit de référencement qui vous aidera à analyser vos pages web